生物标志物 生物标志物
Vishal Deshwal1, Arush Jasuja2, Harsh Bhasin3
1International Centre for Neuromorphic Systems (ICNS), Western Sydney Universiy, Sydney, NSW, Australia.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究引入了一种新的深度学习框架,用于使用结构性MRI检测早期痴呆症. 该模型准确地分类了轻度认知障碍转换器,为临床环境提供了具有成本效益的诊断工具.
科学领域:
- 神经成像是一种神经成像.
- 人工智能的人工智能
- 医学诊断 医学诊断 医学诊断
背景情况:
- 轻度认知障碍 (MCI) 是痴呆症的早期指标,需要早期检测及时干预.
- 传统的二维和三维卷积神经网络 (CNN) 在空间相关性分析和MCI分类的计算效率方面存在局限性.
- 对MCI转换器 (MCI-C) 和非转换器 (MCI-NC) 的准确分类对于预测痴呆症进展至关重要.
研究的目的:
- 开发和验证一种新的基于序列的框架,用于使用结构性MRI (s-MRI) 来分类MCI-C和MCI-NC.
- 克服MCI诊断现有的深度学习模型的计算和空间相关性限制.
- 分析灰质衰变模式,以改善早期痴呆症检测.
主要方法:
- 利用来自阿尔茨海默氏病神经成像计划 (ADNI) 187名受试者的s-MRI数据 (75名MCI-C,112名MCI-NC).
- 从每人106张MRI切片中提取特征,使用局部二进制模式 (LBP) 和其变体,创建特征向量.
- 采用基于层层的自适应神经关激活 (LASA) 的双向循环神经网络 (BiRNN) 来建模MRI切片之间的时间和空间关系.
主要成果:
- 拟议的模型表现出强大的概括性能,验证准确度超过训练准确度.
- 在30个实验中获得了97.4% (±0.2标准偏差) 的平均精度.
- 该模型在分类MCI亚型中的有效性和可靠性得到证实.
结论:
- 这种新型框架为早期MCI诊断提供了高精度和边缘设备兼容性.
- 这种方法在各种医疗保健环境中,包括资源有限的环境中,促进了成本效益和可访问的痴呆症诊断.
- 该方法为早期痴呆症检测提供了传统深度学习模型的有效和实用替代方案.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516